Skip to main content
. Author manuscript; available in PMC: 2008 Oct 6.
Published in final edited form as: Pharmacol Ther. 2006 Feb 3;110(3):465–502. doi: 10.1016/j.pharmthera.2005.09.008

Table 1.

The localization of the phosphorylation sites relevant for arrestin binding on the cytoplasmic elements of different GPCRs

Cytoplasmic element Receptor References
C-terminus Chemokine receptors CCR5 Huttenrauch et al., 2002; Kraft et al., 2001
Chemokine receptor CCR7 Kohout et al., 2004
Angiotensin II receptor type 1A Qian et al., 2001
Thyrotropin-releasing Hanyaloglu et al., 2001
hormone receptor
Parathyroid hormone receptor Vilardaga et al., 2002
N-formyl peptide receptor Key et al., 2003
β1-Adrenergic receptor Liang et al., 2003a
Substance P receptor Richardson et al., 2003
Prostaglandin E2 receptor subtype EP4 Neuschafer-Rube et al., 2004
Corticotropin-releasing hormone receptor type 1alpha Teli et al., 2005
Orexin-1 receptor Milasta et al., 2005
Protease-activated receptor-2 Stalheim et al., 2005
Cysteinyl leukotriene type 1 receptor Naik et al., 2005
Neuropeptide Y Y1 receptor Holliday et al., 2005
Somatostatin receptor 2A m2 muscarinic cholinergic receptor Tulipano et al., 2004
i3 (3rd loop) Lee et al., 2000, Pals-Rylaarsdam et al., 1997
α2A-adrenoceptor Wang & Limbird, 2002
Gonadotropin receptor Bhaskaran et al., 2003, Kishi et al., 2002
Dopamine receptor D1 Kim et al., 2004
Dopamine receptor D2 Namkung & Sibley, 2004
i2 (2nd loop) mu-opioid receptor Celver et al., 2001, 2004, Lowe et al., 2002
i1 (1st loop) Follitropin receptor Kishi et al., 2002